New injection could slash morphine use after spinal fusion
NCT ID NCT04904575
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a numbing injection called an erector spinae plane block can lower the amount of morphine patients need after lumbar spinal fusion surgery. Researchers will compare morphine use over 72 hours in 130 adults receiving either the block or a placebo. The goal is to improve pain control while reducing opioid-related side effects.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- erector spinae plane block (a numbing injection near the spine)
- What this could lead to
- If it works, this could offer a way to reduce opioid painkiller use after back surgery, leading to fewer side effects and faster recovery.
- What could go wrong
- This is a relatively small, single-center trial. The block may not significantly reduce morphine use, and there are always risks like infection or nerve damage from the injection.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 130 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jan 2022
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patient with medical insurance. * Patient who received information about study and signes a consent to participate in the study. * Major patient requiring a lumbar spinal fusion surgery. * Patient with an ASA score of 1, 2 or 3. Exclusion Criteria: * Minor patient. * Patient with morphine intolerance * Patient with allergy to local anesthetics. * Patient consuming morphine for more than 3 months. * Pregnant or breastfeeding patient. * Patient scheduled for cancer surgery or trauma surgery. * Patient participating in another interventional study. * Patient with history of lumbar spinal fusion. * Patient requiring lumbar surgery without arthrodesis. * Patient requiring lumbar surgery with inter-lamar or inter-epineal stabilization. * Patient refusing to sign the consent form. * Patient for whom it is impossible to give informed information. * Patient under the protection of justice, under curatorship or under tutorship.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Lumbar spinal fusion are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Clinique Saint Jean
RECRUITINGSaint-Jean-de-Védas, 34430, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.